Yu Jing, Han Qi, Cui Yulan
Department of Gynaecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, P.R. China.
Tumour Biol. 2017 Jul;39(7):1010428317709129. doi: 10.1177/1010428317709129.
Long non-coding RNAs play important roles in the regulation of cellular processes including cell proliferation, differentiation, and metastasis. The dysregulation of long non-coding RNAs, such as the SPRY4-IT1 (SPRY4 intronic transcript 1), has been associated with various types of malignancies. However, the functional roles and regulatory mechanism of SPRY4-IT1 in ovarian cancer remain to be elucidated. Here, we quantified the expression level of SPRY4-IT1 in ovarian cancer patients and found its downregulation in ovarian cancer tissues compared to the adjacent normal tissues. Patients with lower SPRY4-IT1 expression were associated with a relatively poor prognosis. In consistency, the expression of SPRY4-IT1 was found to be reduced in four human ovarian cancer cell lines compared to normal ovarian epithelial cells. Next, two ovarian cancer cell lines SKOV3 and HO8910 were employed in vitro assays to investigate biological functions of SPRY4-IT1 in ovarian cancer. The cell proliferation was reduced following SPRY4-IT1 overexpression in SKOV3/HO8910 cells based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and colony formation assays. The SPRY4-IT1 overexpression also dramatically arrested cell cycle and promoted cell apoptosis. Both wound-healing and transwell-based assays demonstrated that cell migration and invasion were inhibited following SPRY4-IT1 overexpression. Meanwhile, overexpression of SPRY4-IT1 increased E-cadherin and decreased N-cadherin and vimentin protein levels, indicating that SPRY4-IT1 may regulate ovarian cancer cell metastasis through the inhibition of epithelial-mesenchymal transition. Taken together, our findings suggest that SPRY4-IT1 regulates various cellular processes of ovarian cancer cells and its downregulation may contribute to ovarian cancer progression and metastasis partly via affecting the epithelial-mesenchymal transition.
长链非编码RNA在包括细胞增殖、分化和转移在内的细胞过程调控中发挥着重要作用。长链非编码RNA的失调,如SPRY4-IT1(SPRY4内含子转录本1),已与多种类型的恶性肿瘤相关。然而,SPRY4-IT1在卵巢癌中的功能作用和调控机制仍有待阐明。在此,我们量化了卵巢癌患者中SPRY4-IT1的表达水平,发现与相邻正常组织相比,其在卵巢癌组织中表达下调。SPRY4-IT1表达较低的患者预后相对较差。同样,与正常卵巢上皮细胞相比,在四种人卵巢癌细胞系中发现SPRY4-IT1的表达降低。接下来,使用两种卵巢癌细胞系SKOV3和HO8910进行体外试验,以研究SPRY4-IT1在卵巢癌中的生物学功能。基于3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐和集落形成试验,在SKOV3/HO8910细胞中过表达SPRY4-IT1后,细胞增殖减少。SPRY4-IT1的过表达还显著使细胞周期停滞并促进细胞凋亡。伤口愈合试验和基于Transwell的试验均表明,过表达SPRY4-IT1后细胞迁移和侵袭受到抑制。同时,SPRY4-IT1的过表达增加了E-钙黏蛋白的表达,并降低了N-钙黏蛋白和波形蛋白的蛋白水平,表明SPRY4-IT1可能通过抑制上皮-间质转化来调节卵巢癌细胞的转移。综上所述,我们的研究结果表明,SPRY4-IT1调节卵巢癌细胞的各种细胞过程,其下调可能部分通过影响上皮-间质转化促进卵巢癌的进展和转移。